These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 18926322)

  • 21. Leptin induces tissue factor expression in human peripheral blood mononuclear cells: a possible link between obesity and cardiovascular risk?
    Napoleone E; DI Santo A; Amore C; Baccante G; di Febbo C; Porreca E; de Gaetano G; Donati MB; Lorenzet R
    J Thromb Haemost; 2007 Jul; 5(7):1462-8. PubMed ID: 17425664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leptin as a Mediator of Obesity-Induced Hypertension.
    Bell BB; Rahmouni K
    Curr Obes Rep; 2016 Dec; 5(4):397-404. PubMed ID: 27665107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Leptin: from gene to energy balance].
    Basdevant A; Ciangura C
    Bull Acad Natl Med; 2007; 191(4-5):887-94; discussion 894-5. PubMed ID: 18225443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain somatic cross-talk: ghrelin, leptin and ultimate challengers of obesity.
    Popovic V; Duntas LH
    Nutr Neurosci; 2005 Feb; 8(1):1-5. PubMed ID: 15909762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leptin resistance in diet-induced obesity: the role of hypothalamic inflammation.
    de Git KC; Adan RA
    Obes Rev; 2015 Mar; 16(3):207-24. PubMed ID: 25589226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications.
    Mark AL; Correia ML; Rahmouni K; Haynes WG
    J Hypertens; 2002 Jul; 20(7):1245-50. PubMed ID: 12131511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Leptin in Cardiovascular Diseases.
    Poetsch MS; Strano A; Guan K
    Front Endocrinol (Lausanne); 2020; 11():354. PubMed ID: 32655492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leptin and the clinical cardiovascular risk.
    Singh M; Bedi US; Singh PP; Arora R; Khosla S
    Int J Cardiol; 2010 Apr; 140(3):266-71. PubMed ID: 19944469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPARalpha activators may be good candidates as antiaging agents.
    Erol A
    Med Hypotheses; 2005; 65(1):35-8. PubMed ID: 15893114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adipose tissue as an endocrine organ.
    Galic S; Oakhill JS; Steinberg GR
    Mol Cell Endocrinol; 2010 Mar; 316(2):129-39. PubMed ID: 19723556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug targeting of leptin resistance.
    Santoro A; Mattace Raso G; Meli R
    Life Sci; 2015 Nov; 140():64-74. PubMed ID: 26071010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lessons from Leptin's molecular biology: Potential therapeutic actions of recombinant leptin and leptin-related compounds.
    Correia ML; Haynes WG
    Mini Rev Med Chem; 2007 Jan; 7(1):31-8. PubMed ID: 17266635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leptin resistance in obesity: An epigenetic landscape.
    Crujeiras AB; Carreira MC; Cabia B; Andrade S; Amil M; Casanueva FF
    Life Sci; 2015 Nov; 140():57-63. PubMed ID: 25998029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity and cardiovascular disease: role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system.
    Lastra G; Sowers JR
    Horm Mol Biol Clin Investig; 2013 Sep; 15(2):49-57. PubMed ID: 25436732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient receptor potential vanilloid type-1 channel regulates diet-induced obesity, insulin resistance, and leptin resistance.
    Lee E; Jung DY; Kim JH; Patel PR; Hu X; Lee Y; Azuma Y; Wang HF; Tsitsilianos N; Shafiq U; Kwon JY; Lee HJ; Lee KW; Kim JK
    FASEB J; 2015 Aug; 29(8):3182-92. PubMed ID: 25888600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenomenon of leptin resistance in seasonal animals: the failure of leptin action in the brain.
    Szczesna M; Zieba DA
    Domest Anim Endocrinol; 2015 Jul; 52():60-70. PubMed ID: 25863197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased cardiovascular risk markers in obesity are associated with body adiposity: role of leptin.
    Gómez-Ambrosi J; Salvador J; Silva C; Pastor C; Rotellar F; Gil MJ; Cienfuegos JA; Frühbeck G
    Thromb Haemost; 2006 Jun; 95(6):991-6. PubMed ID: 16732378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The regulation of aldosterone secretion by leptin: implications in obesity-related cardiovascular disease.
    Faulkner JL; Bruder-Nascimento T; Belin de Chantemèle EJ
    Curr Opin Nephrol Hypertens; 2018 Mar; 27(2):63-69. PubMed ID: 29135585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leptin and the regulation of endothelial function in physiological and pathological conditions.
    Bełtowski J
    Clin Exp Pharmacol Physiol; 2012 Feb; 39(2):168-78. PubMed ID: 21973116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leptin resistance of adipocytes in obesity: role of suppressors of cytokine signaling.
    Wang Z; Zhou YT; Kakuma T; Lee Y; Kalra SP; Kalra PS; Pan W; Unger RH
    Biochem Biophys Res Commun; 2000 Oct; 277(1):20-6. PubMed ID: 11027633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.